Rana H. Besada

In vivo RNAi screening identifies Pafah1b3 as a target for combination therapy with TKIs in BCR-ABL1+ BCP-ALL.

M. Hemann, A. Bhutkar, Eleanor R. C. Fiedler, 2018, Blood advances.

A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer

Ying S. Ting, R. Govindan, Michael S. Rooney, 2020, Cell.

Endocardially Derived Macrophages Are Essential for Valvular Remodeling.

Rajan P. Kulkarni, M. Pellegrini, Bin Zhou, 2019, Developmental cell.

Combined TCR Repertoire Profiles and Blood Cell Phenotypes Predict Melanoma Patient Response to Personalized Neoantigen Therapy plus Anti-PD-1

Michael S. Rooney, R. Gaynor, P. Ott, 2020, Cell reports. Medicine.